HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria.

Abstract
Intermittent acute porphyria has recently been distinguished biochemically from other genetic hepatic porphyrias by the observation of diminished hepatic uroporphyrinogen I synthetase activity and increased delta-aminolevulinic acid synthetase activity. Since deficient uroporphyrinogen I synthetase may be reflected in nonhepatic tissues, we have assayed this enzyme in red cell hemolysates from nonporphyric subjects and from patients with genetic hepatic porphyria. Only patients with intermittent acute porphyria had decreased erythrocyte uroporphyrinogen I synthetase activity which was approximately 50% of normal. The apparent K(m) of partially purified uroporphyrinogen I synthetase was 6 x 10(-6)m in both nonporphyrics and patients with intermittent acute porphyria. These data provide further evidence for a primary mutation affecting uroporphyrinogen I synthetase in intermittent acute porphyria. Further-more, results of assay of red cell uroporphyrinogen I synthetase activity in a large family with intermittent acute porphyria suggest that this test may be a reliable indicator of the heterozygous state.
AuthorsL J Strand, U A Meyer, B F Felsher, A G Redeker, H S Marver
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 51 Issue 10 Pg. 2530-6 (Oct 1972) ISSN: 0021-9738 [Print] United States
PMID5056653 (Publication Type: Journal Article)
Chemical References
  • Porphyrins
  • Porphobilinogen
  • Lyases
Topics
  • Acute Disease
  • Chromatography, DEAE-Cellulose
  • Chromatography, Gel
  • Chromatography, Thin Layer
  • Erythrocytes (enzymology)
  • Female
  • Heterozygote
  • Humans
  • Kinetics
  • Lyases (blood, isolation & purification)
  • Male
  • Pedigree
  • Porphobilinogen
  • Porphyrias (blood, diagnosis, enzymology)
  • Porphyrins (biosynthesis)
  • Spectrometry, Fluorescence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: